This brand name is authorized in United States
The drug TURALIO contains one active pharmaceutical ingredient (API):
|
1
Pexidartinib
UNII YS6WAI3XN7 - PEXIDARTINIB HYDROCHLORIDE
|
|
Pexidartinib is a small molecule tyrosine kinase inhibitor that targets colony stimulating factor 1 receptor (CSF1R), KIT proto-oncogene receptor tyrosine kinase (KIT), and FMS-like tyrosine kinase 3 (FLT3) harboring an internal tandem duplication (ITD) mutation. Overexpression of the CSF1R ligand promotes cell proliferation and accumulation in the synovium. Pexidartinib is used for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT). |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| TURALIO Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 65597-402 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
